What's New
Last Posted: Nov 04, 2019
- Realizing the Dream of Molecularly Targeted Therapies for Cystic Fibrosis.
Collins Francis S et al. The New England journal of medicine 2019 Oct - Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial
HGM Heijerman et al, Lancet, October 31, 2019 - Elexacaftor–Tezacaftor–Ivacaftor for Cystic Fibrosis with a Single Phe508del Allele
PJ Middleton et al, NEJM, October 31, 2019 - FDA approves new breakthrough therapy for cystic fibrosis- Treatment approved for approximately 90% of patients with cystic fibrosis, many of whom had no approved therapeutic options
FDA News Release, October 2019 - Studies Yield ‘Impressive’ Results in Fight Against Cystic Fibrosis
N Chokshi, NY Times, October 31, 2019 - New Hope For Patients Living With Cystic Fibrosis After Scientists Unveil Therapy
NPR, November 1, 2019 - Dare to Dream: The Long Road to Targeted Therapies for Cystic Fibrosis
NIH Director's Blog, October 31, 2019 - Biomarkers for Clinical Decision-Making in the Management of Pulmonary Embolism.
Giannitsis Evangelos et al. Clinical chemistry 2017 Jan 63(1) 91-100 - Immunoreactive trypsinogen levels in newborn screened infants with an inconclusive diagnosis of cystic fibrosis.
Ooi Chee Y et al. BMC pediatrics 2019 Oct 19(1) 369 - Factors affecting the growth of infants diagnosed with cystic fibrosis by newborn screening.
Patterson K D et al. BMC pediatrics 2019 Oct 19(1) 356 - A comparative study of machine learning classifiers for risk prediction of asthma disease.
Ullah Rahat et al. Photodiagnosis and photodynamic therapy 2019 Oct - Identifying tuberculous pleural effusion using artificial intelligence machine learning algorithms.
Ren Zenghua et al. Respiratory research 2019 Oct 20(1) 220 - Predicting post-stroke pneumonia using deep neural network approaches.
Ge Yanqiu et al. International journal of medical informatics 2019 Oct 132103986 - Systems biology and big data in asthma and allergy - recent discoveries and emerging challenges.
Tang Howard H F et al. The European respiratory journal 2019 Oct - EGFR T790M ctDNA testing platforms and their role as companion diagnostics: Correlation with clinical outcomes to EGFR-TKIs.
Liang Zhiyong et al. Cancer letters 2017 403186-194 - Guidelines for Pathologic Diagnosis of Malignant Mesothelioma 2017 Update of the Consensus Statement From the International Mesothelioma Interest Group.
Husain Aliya Noor et al. Archives of pathology & laboratory medicine 2018 Jan 142(1) 89-108 - Understanding Precision Medicine And AI Within The Life Cycle Of Technology Revolutions
D Shaywitz, Forbes, October 16, 2019 - African American children may need different asthma treatments
NIH, October 2019 - The future of cystic fibrosis care: a global perspective.
Bell Scott C et al. The Lancet. Respiratory medicine 2019 Sep - A Drug Was Made For Just One Child, Raising Hopes About Future Of Tailored Medicine
A Chen, WBUR, October 11, 2019
.png)
No hay comentarios:
Publicar un comentario